TrialClinical ophthalmology (Auckland, N.Z.)2026

Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.

Jay S Pepose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.